{"pmid": "12114401", "sentences": {"sent_1": {"Section": "", "text": "The data presented here were obtained from 17 patients enrolled in a Phase I trial who received five dose levels of BMS - 247550 ( 7.4 - 59.2 mg / m ( 2 ) ) , given as a 1 - h infusion once every 3 weeks .", "entities": {"entity_1": {"text": "BMS", "class": "Intervention", "negation": 0, "UMLS": "", "index": 1, "start": 21}, "attribute_1": {"text": "7.4 - 59.2 mg / m", "class": "measure", "negation": 0, "UMLS": "", "index": 2, "start": 25}}, "relations": {}}, "sent_2": {"Section": "", "text": "Plasma drug exposure or area under the curve ( AUC ) , and tubulin bundle formation in PBMCs were assessed in cycles 1 and 2 .", "entities": {"entity_2": {"text": "Plasma drug exposure", "class": "Outcome", "negation": 0, "UMLS": "C0743284:drug exposure,C0032105:Plasma,", "index": 1, "start": 0}, "entity_3": {"text": "area under the curve ( AUC )", "class": "Outcome", "negation": 0, "UMLS": "", "index": 2, "start": 4}, "entity_4": {"text": "tubulin bundle formation", "class": "Outcome", "negation": 0, "UMLS": "", "index": 3, "start": 13}, "entity_5": {"text": "PBMCs", "class": "Participant", "negation": 0, "UMLS": "", "index": 4, "start": 17}}, "relations": {}}, "sent_3": {"Section": "", "text": "Similar analyses were also performed on tumor biopsies from one eligible patient .", "entities": {"entity_6": {"text": "tumor biopsies", "class": "Outcome", "negation": 0, "UMLS": "C0005558:biopsies,C0027651:tumor,", "index": 1, "start": 6}}, "relations": {}}}}